PDE4 inhibitors (5)
Hormonal agents (2)
Carboxylic acids (1)
Cyclic compounds (1)
Nasal sprays (1)
Organic acids (1)
AK Scientific (4)
Sigma Aldrich (4)
TCI Chemicals (3)
Oakwood Chemical (1)
FLUTICASONE PROPIONATE (80474-14-2)
Fluticasone propionate belongs to a class of drugs known as corticosteroids, specifically glucocorticoids, which are hormones that predominantly affect the metabolism of carbohydrates and, to a lesser extent, fat and protein. It is used to treat asthma, allergic rhinitis, nasal polyps, various skin disorders and Crohn's disease and ulcerative colitis. It is also used to treat eosinophilic esophagitis.
Roflumilast (trade names Daxas, Daliresp) is a drug that acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4). It has anti-inflammatory effects and is used as an orally administered drug for the treatment of inflammatory conditions of the lungs such as chronic obstructive pulmonary disease (COPD). In June 2010, it was approved in the EU for severe COPD associated with chronic bronchitis.
Trental · Torental · Pentoxil
Pentoxifylline, also known as oxpentifylline, is a xanthine derivative used as a drug to treat muscle pain in people with peripheral artery disease. It is generic and sold under many brand names worldwide.
BECLOMETHASONE DIPROPIONATE (5534-09-8)
Beclomethasone · Vanceril · Beconase
Beclometasone dipropionate, also spelled beclomethasone dipropionate and sold under the brand name Qvar among others, is a steroid medication. It is available as an inhaler, cream, pills, and nasal spray. The inhaled form is used in the long-term management of asthma.
Luteoline · 3',4',5,7-Tetrahydroxy-Flavone · 3',4',5,7-Tetrahydroxyflavone
Luteolin is a flavone, a type of flavonoid, with a yellow crystalline appearance.
HWA 285 · 1-(5'-oxohexyl)-3-methyl-7-propylxanthine · HWA-285
Propentofylline (HWA 285) is a xanthine derivative with purported neuroprotective effects.
Cilomilast (INN, codenamed SB-207,499, proposed trade name Ariflo) is a drug which was developed for the treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). It is orally active and acts as a selective phosphodiesterase-4 inhibitor. Phosphodiesterase (PDE) inhibitors, such as theophylline, have been used to treat COPD for centuries; however, the clinical benefits of these agents have never been shown to outweigh the risks of their numerous adverse effects.